Results 1 to 10 of about 2,854,763 (331)

Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders [PDF]

open access: yesCells, 2021
Platelets are conventionally defined as playing a vital role in homeostasis and thrombosis. This role has over the years transformed as knowledge regarding platelets has expanded to include inflammation, cancer progression, and metastasis.
Lisa Repsold, Anna Margaretha Joubert
doaj   +3 more sources

Hereditary myeloproliferative disorders

open access: yesHaematologica, 2010
Hereditary forms of myeloproliferative disorders (MPD) can be divided into two broad categories. First, inherited syndromes that affect a single lineage with Mendelian inheritance, high penetrance and polyclonal hematopoiesis, and second, inherited predisposition to true MPD, characterized by ...
Radek C. Skoda
doaj   +5 more sources

Pulmonary hypertension in patients with chronic myeloproliferative disorders [PDF]

open access: yesEuropean Respiratory Review, 2015
Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary ...
Yochai Adir, Davide Elia, Sergio Harari
doaj   +3 more sources

Eosinophilic myeloproliferative disorders. [PDF]

open access: yesHematology Am Soc Hematol Educ Program, 2011
AbstractDespite recent attempts to define and classify patients with marked eosinophilia and features consistent with myeloproliferative disease, areas of controversy remain. These are particularly apparent in situations in which multiple lineages are involved in a clonal process and clinical manifestations are overlapping. Although the introduction of
Klion AD.
europepmc   +6 more sources

A review of current knowledge of myeloproliferative disorders in the horse [PDF]

open access: yesActa Veterinaria Scandinavica, 2021
Myeloid disorders are conditions being characterized by abnormal proliferation and development of myeloid lineage including granulocytes (neutrophils, eosinophils and basophils), monocytes, erythroids, and megakaryocytes precursor cells. Myeloid leukemia,
Katy Satué   +2 more
doaj   +2 more sources

Chorea and Cognitive Impairment in JAK2V617F-Positive Myeloproliferative Disorders: A Case Report and Literature Review [PDF]

open access: yesMedicina, 2023
Chorea is a hyperkinetic movement disorder, accompanied by dystonia, myoclonus, tics, stereotypies, and tremors. It is characterized by excessive, purposeless movements that are distressing, irregularly timed, and randomly distributed.
Ioana Butnariu   +7 more
doaj   +2 more sources

Erythromelalgia: An Uncommon Presentation Precipitated by Aspirin Withdrawal [PDF]

open access: yesCase Reports in Medicine, 2012
Erythromelalgia is a rare disorder frequently associated with myeloproliferative disorders. We describe a case of elderly patient diagnosed with myeloproliferative disorder in remission.
Fatima Khalid   +4 more
doaj   +3 more sources

Myelodysplastic/myeloproliferative disorders

open access: yesHaematologica, 2008
Most patients with myelodysplastic syndromes present with anemia, while neutropenia, thrombocytopenia, or both may be found initially or may appear later.[1][1] Therefore cytopenia, frequently pancytopenia (i.e., reduced counts of red blood cells, white blood cells and platelets in peripheral ...
Luca Malcovati, Mario Cazzola
doaj   +4 more sources

JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms [PDF]

open access: yesAdvances in Hematology, 2012
JAK2 is a tyrosine kinase gene that plays an essential role in the development of normal haematopoiesis. Hyperactivation of JAK2 occurs in myeloproliferative neoplasms by different mechanisms.
Mar Bellido, Peter A. W. te Boekhorst
doaj   +5 more sources

Chronic Myeloproliferative Disorders

open access: bronzeHematology, 2003
AbstractThe Philadelphia chromosome-negative chronic myeloproliferative disorders (CMPD), polycythemia vera (PV), essential thrombocythemia (ET) and chronic idiopathic myelofibrosis (IMF), have overlapping clinical features but exhibit different natural histories and different therapeutic requirements.
Jerry L. Spivak   +6 more
openalex   +4 more sources

Home - About - Disclaimer - Privacy